Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kenneth Blum, David Han, Edward J. Modestino, Scott Saunders, A. Kennison Roy$suffix/text()$suffix/text(), W. Jacobs, Darryl S. Inaba, David Baron, Marlene Oscar-Berman, Mary Hauser, Rajendra D. Badgaiyan, David E. Smith, John Femino & Mark S. Gold. (2018) A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone. Substance Use & Misuse 53:2, pages 220-229.
Read now
Read now
Caroline Victorri-Vigneau, Morgane Rousselet, Marie Grall-Bronnec, Regis Bouquié, Emeric Belliot, Marylène Guerlais, Jean-Yves Guillet & Pascale Jolliet. (2016) Use of psychotropic drug urine test strips in opiate maintenance therapy: A clinical assessment of its advantages. Substance Abuse 37:4, pages 584-590.
Read now
Read now
Laxmaiah Manchikanti, Mark V Boswell & Joshua A Hirsch. (2013) Lessons learned in the abuse of pain-relief medication: a focus on healthcare costs. Expert Review of Neurotherapeutics 13:5, pages 527-544.
Read now
Read now
Jeffrey A. Gudin. (2012) Clinical Strategies for the Primary Health Care Professional to Minimize Prescription Opioid Abuse. Postgraduate Medicine 124:3, pages 131-138.
Read now
Read now
Articles from other publishers (17)
Gwendolyn A. McMillin, Kamisha L. Johnson-Davis, Brian N. Kelly, Bonnie ScottYifei K. Yang. (2021) Impact of the Opioid Epidemic on Drug Testing. Therapeutic Drug Monitoring 43:1, pages 14-24.
Crossref
Crossref
Zhao Li & Ping Wang. (2020) Point-of-Care Drug of Abuse Testing in the Opioid Epidemic. Archives of Pathology & Laboratory Medicine 144:11, pages 1325-1334.
Crossref
Crossref
Sangeeta Tanna, John Ogwu & Graham Lawson. (2020) Hyphenated mass spectrometry techniques for assessing medication adherence: advantages, challenges, clinical applications and future perspectives. Clinical Chemistry and Laboratory Medicine (CCLM) 58:5, pages 643-663.
Crossref
Crossref
Kristin Ashford, Amanda Fallin-Bennett, Andrea McCubbin, Amanda Wiggins, Sheila Barnhart & Josh Lile. (2019) Associations of first trimester co-use of tobacco and Cannabis with prenatal immune response and psychosocial well-being. Neurotoxicology and Teratology 73, pages 42-48.
Crossref
Crossref
Gagan Mahajan. 2018. Essentials of Pain Medicine. Essentials of Pain Medicine
405
418.e2
.
Gagan Mahajan. (2017) Role of Urine Drug Testing in the Current Opioid Epidemic. Anesthesia & Analgesia 125:6, pages 2094-2104.
Crossref
Crossref
. (2017) Appropriate Use of Drug Testing in Clinical Addiction Medicine. Journal of Addiction Medicine 11:1, pages 1-56.
Crossref
Crossref
Catherine Y. Choi. (2016) Chronic pain and opiate management. Disease-a-Month 62:9, pages 334-345.
Crossref
Crossref
Cheng-ting Lee, Trang T. Vo, Abigail S. Cohen, Shihab Ahmed, Yi Zhang, Jianren Mao & Lucy Chen. (2016) Profiles of Urine Drug Test in Clinical Pain Patients vs Pain Research Study Subjects. Pain Medicine, pages pme12900.
Crossref
Crossref
Sangeeta Tanna & Graham Lawson. 2016. Analytical Chemistry for Assessing Medication Adherence. Analytical Chemistry for Assessing Medication Adherence
87
127
.
Gwendolyn A. McMillinStephanie J. MarinKamisha L. Johnson-DavisBryan G. LawlorFrederick G. Strathmann. (2015) A Hybrid Approach to Urine Drug Testing Using High-Resolution Mass Spectrometry and Select Immunoassays. American Journal of Clinical Pathology 143:2, pages 234-240.
Crossref
Crossref
Kenneth Blum, David Han, John Femino, David E. Smith, Scott Saunders, Thomas Simpatico, Stephen J. Schoenthaler, Marlene Oscar-Berman & Mark S. Gold. (2014) Systematic Evaluation of “Compliance” to Prescribed Treatment Medications and “Abstinence” from Psychoactive Drug Abuse in Chemical Dependence Programs: Data from the Comprehensive Analysis of Reported Drugs. PLoS ONE 9:9, pages e104275.
Crossref
Crossref
Audrey Lehmann, Parisa Aslani, Rana Ahmed, Jennifer Celio, Aurelie Gauchet, Pierrick Bedouch, Olivier Bugnon, Benoît Allenet & Marie Paule Schneider. (2013) Assessing medication adherence: options to consider. International Journal of Clinical Pharmacy 36:1, pages 55-69.
Crossref
Crossref
Alec B. O’Connor, Dennis C. Turk, Robert H. Dworkin, Nathaniel P. Katz, Robert Colucci, Jennifer A. Haythornthwaite, Michael Klein, Charles O’Brien, Kelly Posner, Bob A. Rappaport, Gary Reisfield, Edgar H. Adams, Robert L. Balster, George E. Bigelow, Laurie B. Burke, Sandra D. Comer, Edward Cone, Penney Cowan, Richard A. Denisco, John T. Farrar, Richard W. Foltin, David J. Haddox, Sharon Hertz, Gary W. Jay, Roderick Junor, Ernest A. Kopecky, Deborah B. Leiderman, Michael P. McDermott, Pamela P. Palmer, Srinivasa N. Raja, Christine Rauschkolb, Michael C. Rowbotham, Cristina Sampaio, Beatrice Setnik, Shannon M. Smith, Marta Sokolowska, Joseph W. Stauffer, Sharon L. Walsh & James P. Zacny. (2013) Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain 154:11, pages 2324-2334.
Crossref
Crossref
Cynthia Lee & Ing-Kang Ho. (2013) Pharmacological Profiles of Oligomerized μ-Opioid Receptors. Cells 2:4, pages 689-714.
Crossref
Crossref
Margaret E. M. Haglund & Eric D. Collins. 2013. The Neuropsychiatry of Headache. The Neuropsychiatry of Headache
63
74
.
Job Harenberg & Roland Kraemer. (2012) Measurement of the new anticoagulants. Thrombosis Research 129, pages S106-S113.
Crossref
Crossref